Thursday, August 13, 2020 11:13:15 AM
This graph is the perfect summation of Nasrat's failed tenure as CEO. It represents nearly $100M spent in R&D (more than $50M for SequestOx alone), but it shows only 5 drugs commercialized in the entire Nasrat era. Only two are significant revenue-producers, and they are half-owned by Nasrat personally. This graph is like the Warren Buffet quote about patience. Over time, with each appearance on the board, it has taken on a more significant symbolic meaning, about repeated failure, than the post seems to comprehend.
Occam's razor: the simplest solution is most likely the right one.
Hanlon's razor: never attribute to malice that which is adequately explained by stupidity.
Recent ELTP News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
